Agomelatine for the treatment of generalised anxiety disorder

Description

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Karam Kostner

A/Prof Karam Kostner

LDL Management – Why it is Important

A/Prof Ralph Audehm

A/Prof Ralph Audehm

Navigating Expanded PBS Access to SGLT2i in General Practice

Prof Deborah Bateson

Prof Deborah Bateson

Cervical Cancer Prevention – Common Questions

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases – When to Use Dual vs Triple Therapy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sean Hood

expert

Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

Date published: 8 August 2022